CURRENT NEWS

• 06.07.2021
  Standigm Secures $10 M From Pavilion Capital to Accelerate Its Global Competitiveness
• 06.07.2021
  Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara (Ustekinumab)
• 06.07.2021
  Surmodics Builds Thrombectomy Portfolio With Acquisition of Vetex Medical Limited
• 06.07.2021
  Forge Biologics and Case Western Reserve University Announce Gene Therapy Workforce Development Partnership
• 06.07.2021
  Eureka Therapeutics Announces New GPRC5D License Agreement With Sanofi to Target Multiple Myeloma
• 06.07.2021
  Numinus Wellness to Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology
• 06.07.2021
  GE Healthcare and SOPHiA GENETICS to Collaborate to Match Treatments to Multimodal Patient Data and Cancer Type
• 06.07.2021
  Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML
• 06.07.2021
  Tetherex Pharmaceuticals Signs Exclusive Worldwide License With Mayo Clinic for Development and Commercialization of a Novel Single-Cycle Adenovirus Vaccine Platform
• 06.07.2021
  Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate
• 06.07.2021
  MIMETAS and Roche Enter Into a Collaboration to Develop Human Disease Models for Drug Development
• 06.07.2021
  SD Biosensor Assures Investors of Sustainable Growth Before IPO
• 06.07.2021
  Huons BioPharma Speeds Up Advance to European Market
• 06.07.2021
  CytoDyn Granted a Significant Patent by USPTO for Methods of Treating Coronavirus Infection With Leronlimab
• 06.07.2021
  Teleflex Announces Real-World Clinical Data Presentations of the UroLift System at the 36th Annual European Association of Urology Congress
• 06.07.2021
  Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine and Venetoclax in TP53-Wild Type Acute Myeloid Leukemia
• 06.07.2021
  TRIO Completes Enrolment for Phase 2 Giredestrant Early Breast Cancer Trial Ahead of Schedule
• 06.07.2021
  Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination With Immunotherapeutic, VTP-300, in Subjects With Chronic Hepatitis B Virus Infection
• 06.07.2021
  Curaleaf International Secures Complete GMP Certification of Second EU GMP Facility in Europe
• 06.07.2021
  ITM Appoints Dr. Sabine Daugelat as Chief Operating Officer

Records per page:

Page

Total: 24132 records.